INGM vs REGN · P/E 19, rev $13.34B vs P/E 14, rev $14.34B
Ingram Micro Holding Corporation (INGM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ingram Micro Holding Corporation (INGM) is a information technology services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported INGM revenue for 2024-12-28 was $13.34B. Net income was $83.1M. Revenue was up 13.4% from 2024-09-28 to 2024-12-28. INGM currently screens at market cap $6.80B and trailing P/E 19.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
INGM currently screens at market cap $6.80B and trailing P/E 19.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the INGM and REGN stock pages for the full models.
Not investment advice.